We showed that 5-HT1B and 5-HT1D receptors promote the key survival factors involved in supporting PaCa cells proliferation and invasion and thus they may be considered as one of the novel potential therapeutic targets in PaCa treatment. Here, HTR1B is linked to permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome.